wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Immunology: Serological Diagnosis of Viral Infections pt 2

Total questions: 32

Worksheet time: 16mins

Name
Class
Date
1.

Target Cells (usually where latency occurs)


Varicella-Zoster Virus

a)

epithelials of oropharynx and B lymphs where can become latent

b)

myeloid cells (neutrophils, monocytes, macrophages)

c)

sensory nerve cells

d)

dorsal root ganglia

2.

Target Cells (usually where latency occurs)


Herpes Simplex Virus (HSV)

a)

epithelials of oropharynx and B lymphs where can become latent

b)

myeloid cells (neutrophils, monocytes, macrophages)

c)

sensory nerve cells

d)

dorsal root ganglia

3.

Target Cells (usually where latency occurs)


Cytomegalovirus

a)

epithelials of oropharynx and B lymphs where can become latent

b)

myeloid cells (neutrophils, monocytes, macrophages)

c)

sensory nerve cells

d)

dorsal root ganglia

4.

Target Cells (usually where latency occurs)


Infectious Mononucleosis

a)

epithelials of oropharynx and B lymphs where can become latent

b)

myeloid cells (neutrophils, monocytes, macrophages)

c)

sensory nerve cells

d)

dorsal root ganglia

5.

Signs & Symptoms

Children: usually asymptomatic

Teens/adults: fever, lymphadenopathy, sore throat

Later, if severe: splenohepatomegaly, periorbital edema

a)

Mono

b)

Rubella

c)

CMV

d)

HSV

e)

VZV

6.

Signs & Symptoms

mild fever, upper respiratory symptoms, transient rash, lymphadenopathy (German measles)

a)

Mono

b)

Rubella

c)

CMV

d)

HSV

e)

VZV

7.

Signs & Symptoms

Primary infections usually asymptomatic, but if symptomatic, similar to IM symptoms, except no sore throat

a)

Mono

b)

Rubella

c)

CMV

d)

HSV

e)

VZV

8.

Signs & Symptoms

fever, blister-like rash on face, scalp, then extremities

a)

Mono

b)

Rubella

c)

CMV

d)

HSV

e)

VZV

9.

Signs & Symptoms

cold sore, genital warts/sores

a)

Mono

b)

Rubella

c)

CMV

d)

HSV

e)

VZV

10.

Which is NOT true of Serum specific antibody detection of Rubella?

IgG and IgM by LA, IFA, EIA, and HI

a)

Diagnose Acute infection: 4-fold rising titers, IgM or IgG

b)

Determine Immune status: IgG >8

c)

Diagnose Congenital infection: High IgM or rising IgM titer

d)

Cannot be tested for during pregnancy

11.

How do you test for Rubella during pregnancy?

a)

check mother's IgG for immune status

b)

check fetus IgG for immune status

c)

check fetus IgM for immune status

d)

Check mother's IgG after 5 days of pregnancy: 4-fold increase in IgG is diagnostic

12.

What does the MMR vaccine do?

a)

Induces both IgM and IgG production for mumps, measles, and Rubella

b)

Carries IgG antibodies to the offspring in pregnant women

c)

all of the above

d)

IgM persists and tested for immune status

13.

Which is NOT a characteristic of the Cytomegalovirus (CMV)?

a)

Can be detected in saliva, stool, urine, cervicovaginal, semen, breast milk, blood

b)

Major issue for transplant or diffusion patients that received latent CMV blood (reactivation infections)

c)

CMV is identical in all aspects to IM

d)

Testing for anti-CMV (ELISA) required for transfusion to neonates and immunocompromised patients

14.

What is the importance of PCR (DNA) testing in CMV?

a)

Help distinguish between latent and active infection in immunocompromised patient

b)

Everyone has have some CMV exposure which makes diagnosis difficult

c)

PCR for CMV is required for transfusion to neonates and immunocompromised patients

d)

Detection of asymptomatic CMV

15.

Congenital infection of herpes is caused by _______.

Fetus: transplacental

Neonate: birth canal

Test IgM

a)

HSV1

b)

HSV2

c)

both

16.

STD (only)

Serum antibody: IgM or IgG: 4-fold titer increase

a)

HSV1

b)

HSV2

c)

both

17.

Cold sore (only)

Serum antibody: IgM or IgG: 4-fold titer increase

a)

HSV1

b)

HSV2

c)

both

18.

STD

Genital lesions can be assayed using DFA or direct EIA

a)

HSV1

b)

HSV2

c)

both

19.

Which Serological Tests for Varicella-Zoster (VZV) is the least helpful because antibody class may not appear until convalescence?

a)

PCR (DNA): skin lesions, CSF, tissue, mononuclear cells

b)

Immune Status: IgG (ELISA)

c)

Congenital: IgM (ELISA)

20.

Antigen detection tests (matching)


diarrhea/stool by EIA/OIA

a)

Rotavirus

b)

Respiratory Syncytial virus (RSV)

c)

Influenza A & B

21.

Antigen detection tests (matching)


n/p swab (EIA/OIA)

a)

Rotavirus

b)

Respiratory Syncytial virus (RSV)

c)

Influenza A & B

22.

Antigen detection tests (matching)


n/p or sputum (EIA/OIA)

a)

Rotavirus

b)

Respiratory Syncytial virus (RSV)

c)

Influenza A & B

23.

Type of Hepatitis

fecal-oral. Contaminated food or water. Contaminated shell fish with epidemics in areas with poor sanitation

Disease progression

Usually self-limiting with recovery in 2-4 weeks

No chronic carrier state

a)

hep. A

b)

hep. B

c)

hep. C

d)

hep. D

e)

hep. E

24.

Type of Hepatitis

fecal-oral (poor sanitation, contaminated food/water)

Seen mainly in underdeveloped countries

Acute, self-limiting infection, except in pregnant women may be fatal

No chronic/carrier state

Laboratory tests not done in the US at the present time

a)

hep. A

b)

hep. B

c)

hep. C

d)

hep. D

e)

hep. E

25.

Type of Hepatitis

Acute onset: active infection damaging the liver, with a long clinical course that may last for 6 months

If chronic infections are active, severe liver damage occurs causing cirrhosis and possibly liver cancer

Chronic/carriers shed HBsAg forever

a)

hep. A

b)

hep. B

c)

hep. C

d)

hep. D

e)

hep. E

26.

Type of Hepatitis

Transmission occurs only if infected with HBV parenterally

a)

hep. A

b)

hep. B

c)

hep. C

d)

hep. D

e)

hep. E

27.

Type of Hepatitis:

Acute infections asymptomatic or mild

Can develop chronic carrier state with progression to cirrhosis and liver cancer

a)

hep. A

b)

hep. B

c)

hep. C

d)

hep. D

e)

hep. E

28.

Hepatitis B Serologic Markers


Acute infection or chronic carrier; infectivity

a)

HBsAg/HBeAg

b)

Anti-HBc (total IgM & IgG)

c)

Anti-HBc (IgM)

d)

Anti-HBe

e)

Anti-HBs

29.

Hepatitis B Serologic Markers


Current or previous infection or carrier

a)

HBsAg/HBeAg

b)

Anti-HBc (total IgM & IgG)

c)

Anti-HBc (IgM)

d)

Anti-HBe

e)

Anti-HBs

30.

Hepatitis B Serologic Markers


Recent acute infection

a)

HBsAg/HBeAg

b)

Anti-HBc (total IgM & IgG)

c)

Anti-HBc (IgM)

d)

Anti-HBe

e)

Anti-HBs

31.

Hepatitis B Serologic Markers


Disease resolution; reduced infectivity

a)

HBsAg/HBeAg

b)

Anti-HBc (total IgM & IgG)

c)

Anti-HBc (IgM)

d)

Anti-HBe

e)

Anti-HBs

32.

Hepatitis B Serologic Markers


Recovery and immunity

a)

HBsAg/HBeAg

b)

Anti-HBc (total IgM & IgG)

c)

Anti-HBc (IgM)

d)

Anti-HBe

e)

Anti-HBs